Below are the financial statements of United Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 1,697.2a | 1,207.7a |
| Marketable investments | 1,569.8a | 1,786.4a |
| Accounts receivable, no allowance for 2024 and 2023 | 279.3a | 278.9a |
| Inventories, net | 157.9a | 111.8a |
| Other current assets | 169.7a | 166.2a |
| Total current assets | 3,873.9a | 3,551a |
| Marketable investments | 1,475.3a | 1,909.8a |
| Goodwill and other intangible assets, net | 111.9a | 114.2a |
| Property, plant, and equipment, net | 1,222.4a | 1,045.4a |
| Deferred tax assets, net | 458.4a | 394.8a |
| Other non-current assets | 222.1a | 151.8a |
| Total assets | 7,364a | 7,167a |
| Liabilities and stockholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable and accrued expenses | 344.5a | 298a |
| Line of credit (current) | 300a | 400a |
| Share tracking awards plan | 11a | 35.4a |
| Other current liabilities | 82.6a | 71a |
| Total current liabilities | 738.1a | 804.4a |
| Line of credit (non-current) | 0a | 300a |
| Other non-current liabilities | 181.9a | 77.8a |
| Total liabilities | 920a | 1,182.2a |
| Stockholders’ equity | — | — |
| Preferred stock | 0a | 0a |
| Common stock | 0.8a | 0.7a |
| Additional paid-in capital | 2,698.9a | 2,549a |
| Accumulated other comprehensive loss | -3.4a | -12.8a |
| Treasury stock | -3,474.5a | -2,579.2a |
| Retained earnings | 7,222.2a | 6,027.1a |
| Total stockholders’ equity | 6,444a | 5,984.8a |
| Total liabilities and stockholders’ equity | 7,364a | 7,167a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.